Search Results - "Ruigrok-Ritstier K"

Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients.

Authors: Sokolova, Tatyana N. Yanus, Grigory A. Aleksakhina, Svetlana N. et al.

Source: Cancers. Jun2025, Vol. 17 Issue 11, p1833. 15p.

Prognostic Value of Pretreatment Circulating Tumor HPV DNA Load in HPV-Associated Cancers: A Systematic Review and Meta-Analysis.

Authors: Jabłońska, Iwona Agnieszka Goławski, Marcin Ścieglińska, Dorota et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4263. 19p.

Cannabidiol and tetrahydrocannabinol in ovarian cancer: A systematic review and Meta-analysis of anticancer efficacy.

Authors: Tong, Siyao Loilome, Watcharin Namwat, Nisana et al.

Source: Oncologie (De Gruyter). Mar2026, Vol. 28 Issue 2, p299-314. 16p.

Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Authors: Jongbloed EM Wortelboer N de Weerd V et al.

Source: Nature medicine [Nat Med] 2025 Nov; Vol. 31 (11), pp. 3662-3667. Date of Electronic Publication: 2025 Sep 04.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells.

Authors: Komar, Zofia M. Ladan, Marjolijn M. Verkaik, Nicole S. et al.

Source: Cancers. Jul2025, Vol. 17 Issue 13, p2109. 14p.

Risks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types.

Authors: Aimagambetova, Gulzhanat Bapayeva, Gauri Ukybassova, Talshyn et al.

Source: Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6318. 16p.

Models of high-grade serous carcinoma of tubo-ovarian origin.

Authors: Padmanabhan, Achuth Dwivedi, Shailendra Merritt, Melissa A. et al.

Source: Oncology Reviews. 2026, p1-23. 23p.

The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).

Authors: Englisz, Aleksandra Smycz-Kubańska, Marta Królewska-Daszczyńska, Patrycja et al.

Source: Diagnostics (2075-4418). May2025, Vol. 15 Issue 10, p1289. 17p.

Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review.

Authors: Pineda-Migranas, Jesús Alejandro Bravata-Alcántara, Juan Carlos Cortés-Ortíz, Iliana Alejandra et al.

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10503. 13p.

Identification and Integration of LRG1-Induced Differentially Expressed Gene (DEG) Hub Profiles in Breast Cancer Cells.

Authors: Osorio-Antonio, Federico Diaz-González, Daniela Michel Campos-Viguri, Gabriela Elizabeth et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 8, p3613. 27p.

Roles of Cancer Histology Type and HPV Genotype in HPV ctDNA Detection at Baseline in Cervical Cancer: Implications for Tumor Burden Assessment.

Authors: Lee, Miseon Lee, Eun Ji Kang, Jun et al.

Source: Pathobiology. 2025, Vol. 92 Issue 3, p123-132. 10p.

On the Quest for Biomarkers: A Comprehensive Analysis of Modified Nucleosides in Ovarian Cancer Cell Lines.

Authors: Mohl, Daniel A. Lagies, Simon Lonzer, Alexander et al.

Source: Cells (2073-4409). May2025, Vol. 14 Issue 9, p626. 22p.

Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers.

Authors: Hutcheson, Joshua Conway, David Kumar, Sunil et al.

Source: Diagnostics (2075-4418). Apr2025, Vol. 15 Issue 7, p825. 14p.

Synergistic Antitumor Activity of Curcumin and the PARP1 Inhibitor PJ34 in Platinum-Sensitive and Resistant Ovarian Cancer Cells.

Authors: Güler, Aşkın Evren Tuncer, Mehmet Cudi Özdemir, İlhan

Source: Cancers. Feb2026, Vol. 18 Issue 4, p620. 35p.

Bone Metastasis in Estrogen Receptor-Positive Breast Cancer: Molecular Insights and Therapeutic Advances.

Authors: Huang, Zhuoran Wu, Yi Li, Yanshu

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p785. 36p.

Liquid Biopsy and Circulating Biomarkers in Head and Neck Cancer: Advancing Non-Invasive Detection and Tailored Management.

Authors: Morelli, Ilaria Ghirardini, Chiara Faccani, Laura et al.

Source: Cancers. Dec2025, Vol. 17 Issue 24, p3974. 33p.

Global Proteomic Determination of the Poly-Pharmacological Effects of PARP Inhibitors Following Treatment of High-Grade Serous Ovarian Cancer Cells.

Authors: Perez, Jesenia M. Barrera-Estrada, Valerie Twigg, Carly A. I. et al.

Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 24, p11820. 20p.

mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells.

Authors: Bulbul, Muhammet Volkan Mermer, Arif Kolbasi, Bircan et al.

Source: Pharmaceuticals (14248247). Dec2024, Vol. 17 Issue 12, p1562. 18p.

Molecular Profiling of Endocrine Resistance in HR+/HER2-Metastatic Breast Cancer: Insights from Extracellular Vesicles-Derived DNA and ctDNA in Liquid Biopsies.

Authors: Martínez-Rodríguez, Ana Fuentes-Antrás, Jesús Lorca, Víctor et al.

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13045. 16p.

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

Authors: Wang, Yuwei Dackus, Gwen M. H. E. Rosenberg, Efraim H. et al.

Source: BMC Medicine. 1/9/2024, Vol. 22 Issue 1, p1-14. 14p.